StockMacro
Company, fund or insider

Help

Menu

Eva Anette Engelhardt

Insider (Form 4 reporting owner): EVP, President, CDG CIK 2024911Name as filed: ENGELHARDT EVA ANETTEIts filings on EDGARAll insiders

Measures activity, not value. Not investment advice.

Since 11 May 2026, sold $136K in 1 sale of Bio-Rad Laboratories, Inc.Class A.

Companies

Role on the latest Form 4 for each; open-market trades counted
CompanyRoleTrades fromtoPurchasesSales
Bio-Rad Laboratories, Inc.Class A BIOEVP, President, CDG11 May 202611 May 2026–1$136K

What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.

Median return minus the sector fund, in percentage points; "too few trades" under 5
Open-market tradesAfter 3 monthsAfter 6 monthsAfter 12 months
After salestoo few trades1 tradetoo few trades1 tradeno trade old enough

For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.

By year

Counted open-market trades, by trade date
YearPurchasesBoughtSalesSoldNet
2026––1$136K-$136K

Every trade

1, newest first; open-market purchases and sales only
Trade dateCompanySideSharesPriceValuePlanned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. Filing
11 May 2026Bio-Rad Laboratories, Inc.Class A BIOSell550$246.54$136KNoForm 4filed 13 May 2026

From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.